Han Shuaijuan, Wen Yang, Yang Fengfan, He Pingli
State Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing, China.
College of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Front Cell Infect Microbiol. 2021 Apr 13;11:662710. doi: 10.3389/fcimb.2021.662710. eCollection 2021.
Chicken egg yolk antibody (IgY), considered as a potential substitute for antibiotics, has been used for preventing pathogens infection in food, human and animals. This study investigated effects of IgY on growth, adhesion inhibitory and morphology of enterotoxigenic (ETEC) K88 , and evaluated the protective effects of IgY on intestinal health and immune response of mice infected with ETEC . Sixty pathogen-free C57BL/6J (4-6 weeks of age) mice were divided into six treatments: control (neither IgY nor ETEC infection), ETEC infection, ETEC-infected mice treated with 250 μL of high-dose (32 mg/mL), medium-dose (16 mg/mL) or low-dose (8 mg/mL) anti-ETEC IgY, or ETEC-infected mice treated with 250 μL of non-specific IgY (16 mg/mL). Anti-ETEC IgY inhibited ETEC growth, reduced adherence of ETEC to intestinal epithelial cells J2 and damaged the morphology and integrity of ETEC cell. Oral administration of anti-ETEC IgY effectively ameliorated ETEC-induced clinical signs, reduced ETEC colonization and intestinal permeability, alleviated inflammatory response through reducing the production and expression of proinflammatory cytokines, improved intestinal morphology, and inhibited excessive activation of the mucosal immune response of challenged mice. The overall protective effects of high-dose and medium-dose anti-ETEC IgY against ETEC infection were more effective. These results suggest that anti-ETEC IgY may function as a promising novel prophylactic agent against enteric pathogens infection.
鸡卵黄抗体(IgY)被认为是抗生素的一种潜在替代品,已被用于预防食品、人和动物中的病原体感染。本研究调查了IgY对产肠毒素大肠杆菌(ETEC)K88生长、黏附抑制及形态的影响,并评估了IgY对感染ETEC的小鼠肠道健康和免疫反应的保护作用。将60只无特定病原体的C57BL/6J(4 - 6周龄)小鼠分为六个处理组:对照组(既不感染IgY也不感染ETEC)、ETEC感染组、用250μL高剂量(32mg/mL)、中剂量(16mg/mL)或低剂量(8mg/mL)抗ETEC IgY处理的ETEC感染小鼠组,或用250μL非特异性IgY(16mg/mL)处理的ETEC感染小鼠组。抗ETEC IgY抑制ETEC生长,减少ETEC对肠道上皮细胞J2的黏附,并破坏ETEC细胞的形态和完整性。口服抗ETEC IgY可有效改善ETEC诱导的临床症状,减少ETEC定植和肠道通透性,通过减少促炎细胞因子的产生和表达减轻炎症反应,改善肠道形态,并抑制受攻击小鼠黏膜免疫反应的过度激活。高剂量和中剂量抗ETEC IgY对ETEC感染的总体保护作用更有效。这些结果表明,抗ETEC IgY可能是一种有前景的新型预防剂,可用于预防肠道病原体感染。